| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |